Skip to main content
OpenTrials

Clinical trial condition

Immunoglobulin A Nephropathy

Explore clinical trials studying Immunoglobulin A Nephropathy. Study availability and eligibility vary by location and protocol.

24 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Immunoglobulin A Nephropathy trial results

Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

NCT07498335

Conditions
Autoimmune Diseases, Berger Disease, Bergers Disease, +20 more
Locations
  • Hackensack Meridian Health Neptune City, New Jersey, United States
  • Cincinnati Childrens Hospital MC Cincinnati, Ohio, United States
  • University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • University of Tennessee Health Science Center- Le Bonheur Research Center Memphis, Tennessee, United States
View Trial Details
Recruiting

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

NCT04663204

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, England, United Kingdom
  • Northern Care Alliance NHS Foundation Trust - Salford Royal Salford, England, United Kingdom
  • Royal Infirmary of Edinburgh & Western General Hospital Edinburgh, Scotland, United Kingdom
  • University Hospital of wales Cardiff, Wales, United Kingdom
View Trial Details
Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

NCT05003986

Conditions
Alport Syndrome, Autoimmune Diseases, Blood Coagulation Disorders, +42 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Nemours Children's Hospital Wilmington, Delaware, United States
  • University of Miami, Leonard M. Miller School of Medicine Miami, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 47 locations
View Trial Details
Recruiting

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

NCT06797518

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Central Florida Kidney Specialists Orlando, Florida, United States
  • Georgia Nephrology Research Inst Lawrenceville, Georgia, United States
View all 18 locations
View Trial Details
Enrolling by Invitation

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

NCT05248659

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Clinical Research Site #336 Birmingham, Alabama, United States
  • Clinical Research Site #325 Los Angeles, California, United States
  • Clinical Research Site #370 Palo Alto, California, United States
  • Clinical Research Site #330 Denver, Colorado, United States
View all 158 locations
View Trial Details
Completed

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

NCT05834738

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic Birmingham, Alabama, United States
  • Fides Clinical Research Atlanta, Georgia, United States
  • NANI Research Oak Brook, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 30 locations
View Trial Details

Related conditions